Team, Inc. (NYSE:TISI – Get Free Report) saw a large drop in short interest in October. As of October 31st, there was short interest totalling 16,800 shares, a drop of 20.8% from the October 15th total of 21,200 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average daily volume of 29,500 shares, the short-interest ratio is currently 0.6 days.
Wall Street Analyst Weigh In
Separately, StockNews.com downgraded shares of Team from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 12th.
View Our Latest Analysis on Team
Team Price Performance
Institutional Investors Weigh In On Team
Several institutional investors and hedge funds have recently added to or reduced their stakes in TISI. Renaissance Technologies LLC bought a new position in Team in the 2nd quarter worth $118,000. Barclays PLC increased its stake in shares of Team by 7.3% in the third quarter. Barclays PLC now owns 274,706 shares of the business services provider’s stock worth $4,189,000 after purchasing an additional 18,733 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Team by 10.3% during the 3rd quarter. Geode Capital Management LLC now owns 42,438 shares of the business services provider’s stock worth $647,000 after purchasing an additional 3,973 shares during the last quarter. 46.57% of the stock is currently owned by institutional investors and hedge funds.
About Team
Team, Inc, together with its subsidiaries, provides a suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services in the United States, Canada, Europe, and internationally. It operates through Inspection and Heat Treating (IHT) and Mechanical Services (MS) segments.
See Also
- Five stocks we like better than Team
- Overbought Stocks Explained: Should You Trade Them?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Consumer Staples Stocks, Explained
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Team Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Team and related companies with MarketBeat.com's FREE daily email newsletter.